A good place to work considering the size - Associate Director Merck Employee Review

3.0
Feb 24, 2015
Recommend
CEO approval
Business Outlook

Pros

I have worked at Merck for 14 years in the IT organization and have been blessed with really good direct managers throughout that time. They have always been good about providing training including class room on and off site and online. When i became a manager I was immediately required to take a five day management leadership course, for example. They have allowed me a good bit of autonomy to determine my own day-to-day as well as longer term objectives in alignment with business objectives. Plenty of structure, but plenty of flexibility within the structure

Cons

over the past 10 years, with reorganizations, mergers, and layoffs, coming nearly yearly, there's a perpetual feeling that your days are numbered. For many of the reorganizations that have led to layoffs, there's very little input from mid-level management about who or which positions are eliminated which tends to lead to good people being let go sometimes in droves, while mediocre to poor performers may still be employed.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All